Atrial Fibrillation Trial, Recruiting NCT06657404 Sponsor: Yumei Xue Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06657404
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have a type of irregular heart rhythm called atrial fibrillation (AF) that is not caused by heart valve problems and is not the short, occasional type — and who were first diagnosed with AF within the last 5 years
  • People whose irregular heart rhythm came back after their first catheter ablation procedure (a treatment to correct the rhythm), lasted more than 24 hours, and did not stop on its own
  • People who are not currently taking certain heart rhythm medications (such as amiodarone, dronedarone, or propafenone) after their ablation procedure, and who are willing to take these types of medications and have no medical reasons to avoid them — OR people who were taking these medications after the procedure but have stopped for more than one month

Who may not be able to join:

  • People who have previously had heart surgery, such as bypass surgery or a heart valve replacement
  • People who also have a disease affecting the heart muscle, such as hypertrophic cardiomyopathy, dilated cardiomyopathy, or ischaemic cardiomyopathy
  • People whose heart ultrasound shows that the left upper chamber of the heart is 50mm or larger in diameter, or who have valve changes related to rheumatic heart disease
  • People with a previous history of thyroid problems
  • People with severe liver or kidney disease, or a history of kidney dialysis
  • People whose heart rate is below 60 beats per minute, or who have certain problems with the heart's electrical conduction system, at the time their heart rhythm returns to normal after the ablation procedure
  • People whose heart pumping strength (left ventricular ejection fraction) is below 40%, or who have severe heart failure symptoms (classified as NYHA class III or IV), after their ablation procedure
  • People who are currently taking part in another clinical trial of a drug or medical device
  • People whom the trial doctors consider should not be included, based on other health conditions or concerns (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13570082363

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Yumei Xue
Registry
ClinicalTrials.gov
Start date
23 October 2024
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

converted to sinus rhythm

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov